Patients taking the highest dose of Zepbound (15mg) in phase 3 clinical trials lost 48 pounds on average at 72 weeks, representing a ~20% body weight reduction
As these powerful meds have demonstrated both positive and negative effects on ocular health, researchers consider this medication class a fruitful area of study
[27] on the antidiabetogenic effect of intestinal factors, and in 1929 by Zung & La Barre [28] on the release of a substance from intestinal mucosa with properties to decrease glycaemia, signalled the start of the development of the incretin concept and the study of the relationships between the gut and the endocrine pancreas
Two of the most advanced, Elafibranor (Genfit) and Seladelpar (CymaBay Therapeutics Inc), did not meet their primary endpoints, were discontinued and together throw into question the whole approach of using PPAR agonists as a NASH treatment class
Seven to nine hours of quality sleep per night is the evidence-supported range for most adults
Understanding Ozempic and Its Use in PCOS Ozempic, known generically as semaglutide, is a medication originally developed and approved to treat type 2 diabetes
%20(1).png)
